← Eichor
Condition: Breast Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Breast Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postopera
Phase 2 · 1 location(s) · Fujian Medical University Union Hospital · NCT05292742AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NA · 1 location(s) · Guo ShiWei · NCT06632886Endoscopic Video-Assisted Nipple-Sparing Mastectomy
NA · 1 location(s) · European Institute of Oncology · NCT07579117Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy
NA · 3 location(s) · Region Örebro County · NCT06777420Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
NA · 3 location(s) · University of Colorado, Denver · NCT03995082KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Phase 1 · 2 location(s) · Christian Hinrichs · NCT05483491A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT04501523Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02830724A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination T
Phase 1 · 3 location(s) · Atridia Pty Ltd. · NCT07358377Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT04138719Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Phase 1/Phase 2 · 10 location(s) · SynDevRx, Inc. · NCT05455619Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Canc
NA · 1 location(s) · Institut Claudius Regaud · NCT07233928Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study
Phase N/A · 1 location(s) · Incheon St.Mary's Hospital · NCT06505577[18F] F-GLN by PET/CT in Breast Cancer
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT03863457A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surg
NA · 1 location(s) · Xijing Hospital · NCT07071402Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Re
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02610439Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Phase 2 · 1 location(s) · George Washington University · NCT06806930A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05837767Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Phase N/A · 1 location(s) · Institute of Oncology Ljubljana · NCT06648148Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Phase 2 · 7 location(s) · Abramson Cancer Center at Penn Medicine · NCT04841148The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer
Phase 2 · 1 location(s) · Indonesia University · NCT05550415A Multi-center Investigation of Family Health.
Phase N/A · 1 location(s) · Odense University Hospital · NCT06433349QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
Phase 2 · 1 location(s) · Fudan University · NCT06786026Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.
NA · 3 location(s) · UNICANCER · NCT07120087taVNS-Paired Breastfeeding to Improve Breastfeeding at Discharge
NA · 1 location(s) · Medical University of South Carolina · NCT06417385Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT07025785Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Phase 2 · 11 location(s) · National Cancer Institute (NCI) · NCT06184750Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of
Phase 4 · 3 location(s) · Ottawa Hospital Research Institute · NCT05753618A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
Phase 1/Phase 2 · 7 location(s) · Nanjing Leads Biolabs Co.,Ltd · NCT07281976
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.